Company: DRTSW
Filing Date: 2025-06-23
Form Type: F-3
Source: 0001213900-25-056744
Chunk: 3

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-06-23
Form: F-3
Chunk 3
---
 on the methods of sale that may be used by the Selling Shareholders, see “Plan of Distribution”
beginning on page 23 of this prospectus.

We may amend or supplement
this prospectus from time to time by filing amendments or supplements as required. You should read this entire prospectus and any amendments
or supplements carefully before you make your investment decision.

We are an “emerging
growth company” as defined in the Jumpstart Our Business Startups Act of 2012, or JOBS Act, and a “foreign private issuer”,
and, as such, we have elected to comply with certain reduced public company reporting requirements for this prospectus and future filings.
See “Summary of the Prospectus—Implications of Being an Emerging Growth Company” and “Summary of the Prospectus—Implications of Being a Foreign Private Issuer.”

Investing in our securities involves a high degree of risk. See “ Risk Factors” beginning on page 6 of this prospectus and other risk factors contained in the documents incorporated by reference herein for a discussion of information that should be considered in connection with an investment in our securities.

Neither the Securities and Exchange Commission, the Israeli Securities Authority nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

<div align='center'>The date of this prospectus is
, 2025.

TABLE OF CONTENTS</div>

| CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS                           |     | ii |
| SUMMARY OF THE PROSPECTUS                                                      |     |  1 |
| THE OFFERING                                                                   |     |  5 |
| RISK FACTORS                                                                   |     |  6 |
| CAPITALIZATION                                                                 |     |  8 |
| USE OF PROCEEDS                                                                |     |  9 |
| DESCRIPTION OF THE SECURITIES                                                  |     | 10 |
| SELLING SHAREHOLDERS                                                           |     | 11 |
| CERTAIN MATERIAL ISRAELI TAX CONSIDERATIONS                                    |     | 12 |
| CERTAIN MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS                        |     | 17 |
| PLAN OF DISTRIBUTION                                                           |     | 23 |
| EXPENSES OF THE OFFERING                                                       |     | 25 |
| LEGAL MATTERS                                                                  |     | 26 |
| EXPERTS                                                                        |     | 27 |
| ENFORCEABILITY OF